Novus Life Sciences Private Limited
Similar suppliers you may like
Medisus Pharma
🇮🇳 India
201811-50 peopleTrading Company/Wholesaler/DistributorOEM manufacturer
Description
Medisus Pharma is a Mumbai-based pharmaceutical company established in 2018, operating as a specialized wholesaler, distributor, and exporter. Led by industry veteran Mr. Ranjeet Singh, the company has built a significant presence in the global pharmaceutical trade, maintaining a workforce of up to 50 employees and an annual turnover between 5 and 25 Cr. As an IndiaMART Verified Exporter with a dedicated Import Export Code, the firm facilitates the international distribution of critical care medications. The company specializes in a comprehensive portfolio of life-saving drugs, with a primary focus on oncology, anti-cancer treatments, HIV medications, and kidney care. Their extensive product range includes specialized injections, capsules, and tablets such as Bevacizumab, Trastuzumab, Lenalidomide, and various anti-fungal and pain relief medications. Medisus Pharma serves as a vital link in the pharmaceutical supply chain, distributing high-quality products from well-known manufacturers to meet diverse medical needs across global markets.
Zydus Lifesciences Ltd
🇮🇳 India
More than 10000 peopleManufacturerHigh capacity factory
Large enterprise group
Own brand
OEM manufacturer
Shipments
12133
Key customer
EVERSANA LIFE SCIENCE
Key market
🇺🇸 United States
Description
Zydus Lifesciences Ltd, also known as Cadila Healthcare Ltd, is a leading global pharmaceutical manufacturer headquartered in Ahmedabad, India. Ranking 4th in the Indian pharmaceutical industry, the company operates a vast network of over 30 manufacturing plants across India, the US, and Brazil. With a workforce exceeding 29,000 employees and a dedicated research team of 1,500 scientists, the company specializes in a diverse range of healthcare solutions including New Chemical Entities (NCEs), vaccines, biosimilars, and complex formulations such as transdermal patches and topical medications. Their extensive product portfolio covers critical therapeutic areas such as oncology, cardio-metabolic diseases, neurosciences, and inflammation. Notable innovations include TwinrabTM, the world's first biosimilar of Adalimumab (Exemptia), and India's first tetravalent inactivated influenza vaccine. As an OEM provider with significant manufacturing capabilities, Zydus Lifesciences serves regulated markets in the US and Europe, as well as high-growth regions in Latin America, South Africa, and over 25 emerging markets worldwide.
pharmaceutical products
TwinRab
